As illustrated by mouse models with an inducible MYC, Myc-driven skin papillomas and osteosarcomas can be reversed upon MYC deactivation.13,14 Since MYC is a potent driver gene in multiple human cancers, this oncoprotein has been listed on the top of the putative drug target list. The gene discussed is MYC; the disease is skin papilloma.